E-LIB Suche - Ergebnisse für: Hugen, Patricia

1

Therapeutic drug monitoring of nelfinavir and indinavir in ..:

Burger, David ; Hugen, Patricia ; Reiss, Peter...
AIDS. 17 (2003) 8 - p. 1157-1165 , 2003

Link: https://doi.org/10.1097/..

2

Authors' Reply:

Hugen, Patricia WH ; Burger, David M
Annals of Pharmacotherapy. 34 (2000) 11 - p. 1349-1349 , 2000

Link: https://doi.org/10.1177/..

3

Carbamazepine–Indinavir Interaction Causes Antiretroviral T..:

Hugen, Patricia WH ; Burger, David M ; Brinkman, Kees...
Annals of Pharmacotherapy. 34 (2000) 4 - p. 465-470 , 2000

Link: https://doi.org/10.1345/..

4

Author's Reply:

Hugen, Patricia WH ; Burger, David M
The Annals of Pharmacotherapy. 34 (2000) - p. 1349-1349 , 2000

Link: https://doi.org/10.1345/..

5

Treatment Failure of Nelfinavir-Containing Triple Therapy C..:

Burger, David M. ; Hugen, Patricia W. H. ; Aarnoutse, Rob E....
Therapeutic Drug Monitoring. 25 (2003) 1 - p. 73-80 , 2003

Link: https://doi.org/10.1097/..

6

Therapeutic drug monitoring of indinavir and nelfinavir to ..:

VAN ROSSUM, ANNEMARIE M. C. ; BERGSHOEFF, ALINA S. ; FRAAIJ, PIETER L. A....
The Pediatric Infectious Disease Journal. 21 (2002) 8 - p. 743-747 , 2002

Link: https://doi.org/10.1097/..

7

Pros and cons of therapeutic drug monitoring of antiretrovi..:

Burger, David M. ; Aarnoutse, Rob E. ; Hugen, Patricia W.H.
Current Opinion in Infectious Diseases. 15 (2002) 1 - p. 17-22 , 2002

Link: https://doi.org/10.1097/..

8

Therapeutic Drug Monitoring of HIV-Protease Inhibitors to A..:

Hugen, Patricia W. H. ; Burger, David M. ; Aarnoutse, Rob E....
Therapeutic Drug Monitoring. 24 (2002) 5 - p. 579-587 , 2002

Link: https://doi.org/10.1097/..

9

The influence of efavirenz on the pharmacokinetics of a twi..:

Aarnoutse, Rob E. ; Grintjes, Karin J. T. ; Telgt, Denise S. C....
Clinical Pharmacology & Therapeutics. 71 (2002) 1 - p. 57-67 , 2002

Link: https://doi.org/10.1067/..

10

Analysis of variation in plasma concentrations of nelfinavi..:

Baede-van Dijk, Patricia A. ; Hugen, Patricia W. H. ; Verweij-van Wissen, Corrien P. W. G. M....
AIDS. 15 (2001) 8 - p. 991-998 , 2001

Link: https://doi.org/10.1097/..

11

Saliva as a Specimen for Monitoring Compliance But Not for ..:

Hugen, Patricia W.H ; Burger, David M. ; de Graaff, Marga...
Therapeutic Drug Monitoring. 22 (2000) 4 - p. 437-445 , 2000

Link: https://doi.org/10.1097/..

12

Once-daily indinavir plus ritonavir: preliminary results of..:

Burger, David M. ; Hugen, Patricia W. H. ; van der Ende, Marchina E....
AIDS. 14 (2000) 16 - p. 2621-2623 , 2000

Link: https://doi.org/10.1097/..

13

No drug–drug interaction between nelfinavir or indinavir an..:

Schippers, Emile F. ; Hugen, Patricia W. H. ; den Hartigh, Jan...
AIDS. 14 (2000) 17 - p. 2794-2795 , 2000

Link: https://doi.org/10.1097/..

14

Development of an indinavir oral liquid for children:

Hugen, Patricia W.H. ; Burger, David M. ; Ter Hofstede, Hadewych J. M...
American Journal of Health-System Pharmacy. 57 (2000) 14 - p. 1332-1339 , 2000

Link: https://doi.org/10.1093/..

15

Limited patient adherence to highly active antiretroviral t..:

Nieuwkerk, Pythia T ; Sprangers, Mirjam A.G ; Burger, David M...
https://research.vumc.nl/en/publications/fdb68b57-e830-4ca0-a3f0-21b7e7c58d53. , 2001

Link: https://research.vumc.nl..